Joseph Cusimano

Dr. Cusimano’s current scholarship focuses on the safe and effective use of psychotropics and demonstrating the value of psychiatric pharmacists. He is currently the principal investigator of a multisite project seeking to develop and validate a patient experience instrument.

Select Publications

• Cusimano J. A pilot psychedelic psychopharmacology elective. Curr Pharm Teach Learn. 2022;14(5):680-685. DOI: 10.1016/j.cptl.2022.04.019.
• Gammal RS, Smith DM, Wiisanen KW, Cusimano JM, Pettit RS, Stephens JW, Walko CM, Yang RH, Dunnenberger HM. The pharmacist’s responsibility to ensure appropriate use of direct-to-consumer genetic testing. J Am Coll Clin Pharm. 2021;4(5):652-658. DOI: 10.1002/jac5.1437.
• Hosanagar A, Cusimano J, Radhakrishnan R. Therapeutic potential of psychedelics in the treatment of psychiatric disorders: Part 2 – Review of the evidence. J Clin Psychiatry. 2021;82(3):20ac13787. DOI: 10.4088/JCP.20ac13787.
• Hosanagar A, Cusimano J, Radhakrishnan R. Therapeutic potential of psychedelics in the treatment of psychiatric disorders: Part 1 – Psychopharmacology and neurobiological effects. J Clin Psychiatry. 2021;82(2):20ac13786. DOI: 10.4088/JCP.20ac13786.
• Cusimano J, VandenBerg A. Long-acting injectable antipsychotics and their use in court-ordered treatment: A cross-sectional survey of psychiatric pharmacists’ perceptions. Ment Health Clin. 2020;10(1):18-24. DOI: 10.9740/mhc.2020.01.018.
• Cusimano J, Martin C, VandenBerg A. Olanzapine-induced edema decreasing serum lithium concentrations: A case report. J Clin Psychopharmacol. 2020;40(5):499-500. DOI: 10.1097/jcp.0000000000001269.
• Cusimano J, VandenBerg A. Low-hanging fruit for getting back on your feet: A critical review of diet and exercise interventions for depression. J Affect Disord Rep. 2020;1:100019. DOI: 10.1016/j.jadr.2020.100019.